0001781151-20-000001.txt : 20200824
0001781151-20-000001.hdr.sgml : 20200824
20200824124726
ACCESSION NUMBER: 0001781151-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200824
DATE AS OF CHANGE: 20200824
EFFECTIVENESS DATE: 20200824
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Longeviti Neuro Solutions, LLC
CENTRAL INDEX KEY: 0001781151
IRS NUMBER: 810718616
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-373915
FILM NUMBER: 201126206
BUSINESS ADDRESS:
STREET 1: 303 INTERNATIONAL CIRCLE, SUITE 190
CITY: HUNT VALLEY
STATE: MD
ZIP: 21030
BUSINESS PHONE: 410-527-1803
MAIL ADDRESS:
STREET 1: 303 INTERNATIONAL CIRCLE, SUITE 190
CITY: HUNT VALLEY
STATE: MD
ZIP: 21030
D
1
primary_doc.xml
X0708
D
LIVE
0001781151
Longeviti Neuro Solutions, LLC
303 INTERNATIONAL CIRCLE, SUITE 190
HUNT VALLEY
MD
MARYLAND
21030
410-527-1803
MARYLAND
None
None
Limited Liability Company
true
2015
Jesse
Christopher
c/o Longeviti Neuro Solutions, LLC
303 International Circle, Suite 190
Hunt Valley
MD
MARYLAND
21030
Executive Officer
Director
Chief Executive Officer and Manager
Lewis
Parker
c/o Longeviti Neuro Solutions, LLC
303 International Circle, Suite 190
Hunt Valley
MD
MARYLAND
21030
Director
Manager
John
Andres
c/o Longeviti Neuro Solutions, LLC
303 International Circle, Suite 190
Hunt Valley
MD
MARYLAND
21030
Director
Manager
Chad
Gordon
c/o Longeviti Neuro Solutions, LLC
303 International Circle, Suite 190
Hunt Valley
MD
MARYLAND
21030
Director
Manager
Matthew
B.
Swartz
c/o Pillsbury Winthrop Shaw Pittman LLP
1650 Tysons Blvd., 14th Floor
McLean
VA
VIRGINIA
22102
Director
Manager
Biotechnology
Decline to Disclose
- 06b
false
2020-08-14
false
true
false
1
8000006
5462584
2537422
This filing covers the sale and issuance of Series C Preferred Units
false
23
0
0
491311
In connection with the financing, the Issuer intends to repurchase a portion of the Issuer's equity currently owned by the CEO of the Issuer.
false
Longeviti Neuro Solutions, LLC
/s/ Jesse Christopher
Jesse Christopher
Chief Executive Officer
2020-08-21